Filing Details
- Accession Number:
- 0001171843-25-002084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-08 09:25:57
- Reporting Period:
- 2025-04-07
- Filing Date:
- 2025-04-08
- Accepted Time:
- 2025-04-08 09:25:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1738021 | Compass Therapeutics Inc. | CMPX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1505148 | Neil Lerner | C/O Compass Therapeutics, Inc. 80 Guest Street, Suite 601 Boston MA 02135 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-04-07 | 20,000 | $1.42 | 320,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.43 per share. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.